Clinical trials
Phase 1 Hyperlipidemias trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
109 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2004 | 2 |
| 2006 | 2 |
| 2007 | 3 |
| 2009 | 2 |
| 2010 | 3 |
| 2011 | 11 |
| 2012 | 4 |
| 2013 | 6 |
| 2014 | 8 |
| 2015 | 9 |
| 2016 | 8 |
| 2017 | 4 |
| 2018 | 6 |
| 2019 | 2 |
| 2020 | 5 |
| 2021 | 1 |
| 2022 | 6 |
| 2023 | 4 |
| 2024 | 5 |
| 2025 | 6 |
| 2026 | 11 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 83 |
| Unknown status | 8 |
| Not yet recruiting | 7 |
| Terminated | 4 |
| Recruiting | 3 |
| Withdrawn | 2 |
| Enrolling by invitation | 1 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pfizer | 9 |
| Addpharma Inc. | 6 |
| Chong Kun Dang Pharmaceutical | 6 |
| Boryung Pharmaceutical Co., Ltd | 5 |
| Jeil Pharmaceutical Co., Ltd. | 5 |
| Shandong Suncadia Medicine Co., Ltd. | 4 |
| Yuhan Corporation | 4 |
| Amgen | 2 |
| AstraZeneca | 2 |
| Corsera Health | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hyperlipidemias | 109 |
| Hypertension | 28 |
| Hypercholesterolemia | 17 |
| Obesity | 9 |
| Dyslipidemias | 8 |
| Cardiovascular Diseases | 7 |
| Diabetes Mellitus | 7 |
| Lipid Metabolism Disorders | 5 |
| Metabolic Diseases | 5 |
| Metabolic Syndrome | 4 |
Trials
Showing 51 to 75 of 109. Each trial links to its page on Pharma Observatory.
9 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.